Restoring 1,000 hormone replacement therapy mass tort cases to the Philadelphia Common Pleas Court's caseload, the Pennsylvania Superior Court ruled it is a question of fact, not of law, whether the plaintiffs could have known at the time of their diagnoses with breast cancer that alleged cause of their cancer was their HRT prescriptions.

Restoring 1,000 hormone replacement therapy mass tort cases to the Philadelphia Common Pleas Court's caseload, the Pennsylvania Superior Court ruled it is a question of fact, not of law, whether the plaintiffs could have known at the time of their diagnoses with breast cancer that alleged cause of their cancer was their HRT prescriptions. The court said jurors, not judges, must decide if the ...

Paul G. Allen, a Microsoft Corp. co- founder who was once the second-richest American, accused 11 companies including Google Inc. and Apple Inc. of infringing patents he holds for online-shopping technology.

A federal judge has set an Oct. 1 trial date for an Arkansas woman who is seeking punitive damages against Wyeth Pharmaceuticals because she got breast cancer after taking hormone replacement therapy.

A federal judge has set an Oct. 1 trial date for an Arkansas woman who is seeking punitive damages against Wyeth Pharmaceuticals because she got breast cancer after taking hormone...

A federal judge has set an Oct. 1 trial date for an Arkansas woman who is seeking punitive damages against Wyeth Pharmaceuticals because she got breast cancer after taking hormone replacement therapy.

Robert Moffat, the former International Business Machines Corp. executive who pleaded guilty in the Galleon Group LLC insider-trading scheme, said accused tipster Danielle Chiesi “played him” to obtain tips.

A Pfizer Inc. unit is seeking to duck responsibility for two women’s breast cancers linked to its Prempro menopause drug, a lawyer argued at the end of a trial.

Title: Weight a Factor in Breast Cancer Risk After HRT Use Category: Health News Created: 8/10/2010 2:10:00 PM Last Editorial Review: 8/11/2010

A new study has found that normal weight women on hormone replacement therapy (HRT) and those who take combination estrogen/progestin therapy (EPT) over a longer time may face a higher risk of breast cancer, according to a report posted on WebMD. EPT drugs include Prempro and Premphase. According to the journal Cancer Epidemiology, Biomarkers & Prevention, [...]